Aardvark Therapeutics (AARD) Amortizatization of Intangibles (2024 - 2026)
Aardvark Therapeutics (AARD) reported Amortizatization of Intangibles of $118000.0 for Q1 2026, up 45.68% on a YoY basis from $81000.0 in Q1 2025, and down 49.36% sequentially from $233000.0 in Q4 2025.
Aardvark Therapeutics (AARD) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Aardvark Therapeutics (AARD) has 3 years of Amortizatization of Intangibles data on file, last reported at $118000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 45.68% year-over-year to $118000.0; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 658.76% YoY), and the FY2025 full-year result was $1.3 million, up 1260.42% from the prior year.
- Amortizatization of Intangibles eased to $118000.0 in Q1 2026, from $233000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $620000.0 in Q2 2025 to a low of $81000.0 in Q1 2025.
- A 3-year average of $253333.3 and a median of $175500.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles surged 142.71% in 2025 and surged 45.68% in 2026, its largest moves.
- Tracing AARD's Amortizatization of Intangibles over 3 years: stood at $96000.0 in 2024, then surged by 142.71% to $233000.0 in 2025, then slumped by 49.36% to $118000.0 in 2026.
- Business Quant data shows AARD's Amortizatization of Intangibles at $118000.0 in Q1 2026, $233000.0 in Q4 2025, and $372000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Aardvark Therapeutics | 143.99 Mn | 24.02 Mn | - | 118,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118,000.00 |
| Mar 31, 2026 | 118,000.00 |
| Dec 31, 2025 | 233,000.00 |
| Dec 31, 2025 | 233,000.00 |
| Sep 30, 2025 | 372,000.00 |
| Sep 30, 2025 | 372,000.00 |
| Jun 30, 2025 | 620,000.00 |
| Jun 30, 2025 | 620,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Dec 31, 2024 | 96,000.00 |
| Dec 31, 2024 | 96,000.00 |